Related Experiment Videos
[The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement]
Lei Meng1, Wen-Hui Ding, Li-Bin Shi
1Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
Objective:
To analyze the clinical features and outcomes of patients with immunoglobulin light-chain amyloidosis (AL) who had heart involvement.
Methods:
Clinical features and outcomes of AL amyloidosis patients with heart involvement in the past 7 years in our hospital were retrospectively analyzed.
Results:
Cardiac involvement was seen in 36 out of the 60 AL patients (60%). The clinical manifestations of cardiac amyloidosis included heart failure (50%), low QRS voltage (47.2%) and pseudomyocardial infarction (33.3%) in electrocardiography, as well as thickening of ventricular wall (63.9%), echo of granular sparkling texture (11.1%), atria dilation (33.3%) and diastolic dysfunction (30.6%) in echocardiography. The prognosis was poor, with a median survival time of 13.9 months.
Conclusion:
Patients of AL amyloidosis with cardiac involvement are not rare. Thickening of ventricular wall and diastolic dysfunction are the most common characteristics. Special attention should be paid to this disease.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Coronary Artery Disease III: Clinical Manifestations